Remove 2026 Remove Healthcare Provider Remove Leads
article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Vast reservoirs of data grow cold as they remain hidden in unstructured, disconnected, and siloed states at a time when pharma is being challenged to form new, more focussed relationships with healthcare professionals (HCPs). billion by 2026, according to research by the Business Research Company. Capturing market share. References.

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. Secondly, pressure on healthcare spending is leading to greater consolidation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts

Clarivate

Starting in 2026, the first ten self-administered Part D drugs in the law’s cross hairs will receive price cuts of 38%-79%. With the passage of the Inflation Reduction Act (IRA), the United States government gained the ability to directly negotiate drug prices with manufacturers.

article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years. It’s amazing we still separate the drug costs from overall healthcare costs,” Sontupe says.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider. healthcare organizations Company Founded Type No. healthcare appeared first on Clarivate.

article thumbnail

Leaders from Boston Children’s Hospital, Google Cloud, MedCity News, Edgilty Inc, and Clarify Health discuss the future of AI in healthcare

Clarify Health

Artificial intelligence (AI) has the potential to affect healthcare in profound ways — propelling better data-driven decisions on diagnoses, treatments, and population health management. health system realize $150 billion in savings by 2026. Reports indicate that AI can help the U.S. Founder and CEO at Edgilty Inc. Ines Vigil, M.D.,

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020. IQVIA Institute, March 2022.